Dapagliflozin Lowers HbA1c, Systolic Blood Pressure and Serum Uric Acid in Patients With Type 2 Diabetes and Hypertension, Regardless of Class of Concomitant Antihypertensive Therapy

被引：0
|
作者：
Weber, Michael A.
Mansfield, Traci A.
Iqbal, Nayyar
Parikh, Shamik J.
Ptaszynska, Agata
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diabetes (Type II); Antihypertensive agents; Blood pressure; Hypertension; Glucose;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13640
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up
    Wilding, J.
    Bailey, C.
    Rigney, U.
    Blak, B.
    Kok, M.
    Emmas, C.
    PRIMARY CARE DIABETES, 2017, 11 (05) : 437 - 444
  • [22] THE EFFECT OF DAPAGLIFLOZIN ON HEDIS PERFORMANCE MEASURES OF HBA1C IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Bell, K.
    Hardy, E.
    De Bruin, T.
    Wei, L.
    Martin, P.
    Ptaszynska, A.
    VALUE IN HEALTH, 2012, 15 (04) : A171 - A172
  • [23] The Relation between Serum Uric Acid and HbA1c Is Dependent upon Hyperinsulinemia in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Cui, Yuliang
    Bu, Hemei
    Ma, Xianghua
    Zhao, Sha
    Li, Xiaona
    Lu, Shan
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [24] Diabetes education lowers HbA1c and weight in a veteran population with Type 2 Diabetes
    Tacker, Deanna
    Harris, Margaret M.
    Carroll, Polly
    Hays, Nicholas
    Johnson, Pippa
    Hakkak, Reza
    FASEB JOURNAL, 2007, 21 (05): : A304 - A304
  • [25] Dapagliflozin as Part of Triple Combination Therapy Helps Reduce HbA1c and Body Weight in Patients With Type 2 Diabetes
    Jabbour, Serge
    Hardy, Elise
    Debruin, Tjerk W.
    Gause-Nilsson, Ingrid
    Rohwedder, Katja
    Martin, Paula
    Parikh, Shamik J.
    DIABETES, 2013, 62 : A306 - A307
  • [26] HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics
    Foo, Valencia
    Quah, Joanne
    Cheung, Gemmy
    Tan, Ngiap Chun
    Ma Zar, Kyi Lin
    Chan, Choi Mun
    Lamoureux, Ecosse
    Wong, Tien Yin
    Tan, Gavin
    Sabanayagam, Charumathi
    JOURNAL OF DIABETES, 2017, 9 (02) : 200 - 207
  • [27] Dapagliflozin therapy for Type 2 diabetes in primary care: effects on HbA1c, weight and blood pressure over two years follow-up
    Wilding, J.
    Bailey, C.
    Rigney, U.
    Blak, B.
    Kok, M.
    Emmas, C.
    DIABETIC MEDICINE, 2017, 34 : 189 - 189
  • [28] The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes
    Wang, Xiaopu
    Pei, Junyu
    Zheng, Keyang
    Liu, Maojun
    Hu, Xinqun
    DIABETES OBESITY & METABOLISM, 2025, 27 (03): : 1208 - 1216
  • [29] Impact of the Integrated Care Pilot on HbA1c, cholesterol and systolic blood pressure levels in patients with diabetes
    Adomaviciute, S.
    Watt, H.
    Soljak, M.
    Car, J.
    Majeed, A.
    DIABETIC MEDICINE, 2014, 31 : 175 - 175
  • [30] Practice pearl: the effect of canagliflozin on HbA1c and blood pressure in patients with type 2 diabetes mellitus
    Guthrie, Robert M.
    POSTGRADUATE MEDICINE, 2015, 127 (08) : 783 - 785
12345